Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives

Leishmaniasis is endemic in 98 countries and territories, with 1.2 million new cases per year, making it a worldwide concern. The deadly visceral form is a leading cause of death from tropical parasitic infections, second only to malaria. Leishmaniasis appears to be increasing in many countries beca...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American Academy of Dermatology Vol. 73; no. 6; pp. 897 - 908; quiz 909-10
Main Authors:	Handler, Marc Z, Patel, Parimal A, Kapila, Rajendra, Al-Qubati, Yasin, Schwartz, Robert A
Format:	Journal Article
Language:	English
Published:	United States 01-12-2015
Subjects:	Animals Antiprotozoal Agents - therapeutic use Disease Progression Endemic Diseases Female Humans Leishmania donovani - isolation & purification Leishmaniasis, Cutaneous - diagnosis Leishmaniasis, Cutaneous - drug therapy Leishmaniasis, Cutaneous - epidemiology Leishmaniasis, Mucocutaneous - diagnosis Leishmaniasis, Mucocutaneous - drug therapy Leishmaniasis, Mucocutaneous - epidemiology Leishmaniasis, Visceral - diagnosis Leishmaniasis, Visceral - drug therapy Leishmaniasis, Visceral - epidemiology Male Prevalence Prognosis Risk Assessment Tropical Climate sandfly bat gerbil kala-azar parasitic disorders protozoan diseases ulcer tropical diseases leishmaniasis dog rodents
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!